Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration
暂无分享,去创建一个
V. Perry | T. Freeman | B. Caughey | J. Manson | M. Barria | Marcelo A Barria | P. Piccardo | James D. Alibhai | R. A. Blanco | Marcelo A. Barria | Richard A. Blanco | Marcelo A. Barria | V. H. Perry | Tom C. Freeman | Jean C Manson
[1] B. McColl,et al. Defining the Microglia Response during the Time Course of Chronic Neurodegeneration , 2015, Journal of Virology.
[2] Tom Michoel,et al. Microglial brain region-dependent diversity and selective regional sensitivities to ageing , 2015, Nature Neuroscience.
[3] Michel Goedert,et al. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein , 2015, Science.
[4] Mathias Jucker,et al. Neurodegenerative diseases: expanding the prion concept. , 2015, Annual review of neuroscience.
[5] J. Trojanowski,et al. Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.
[6] C. de Wolf,et al. Prion Protein-Specific Antibodies that Detect Multiple TSE Agents with High Sensitivity , 2014, PloS one.
[7] J. Ironside,et al. Molecular Barriers to Zoonotic Transmission of Prions , 2014, Emerging infectious diseases.
[8] V. Sim,et al. Early Increase and Late Decrease of Purkinje Cell Dendritic Spine Density in Prion-Infected Organotypic Mouse Cerebellar Cultures , 2013, PloS one.
[9] M. Horiuchi,et al. Absence of CD14 Delays Progression of Prion Diseases Accompanied by Increased Microglial Activation , 2013, Journal of Virology.
[10] H. Kretzschmar,et al. Comparative Analysis of Gene Expression Profiles Between Cortex and Thalamus in Chinese Fatal Familial Insomnia Patients , 2013, Molecular Neurobiology.
[11] V. Perry,et al. Regulation of Microglial Proliferation during Chronic Neurodegeneration , 2013, The Journal of Neuroscience.
[12] B. Caughey,et al. Prion Seeding Activities of Mouse Scrapie Strains with Divergent PrPSc Protease Sensitivities and Amyloid Plaque Content Using RT-QuIC and eQuIC , 2012, PloS one.
[13] Emily V. Chambers,et al. Mechanism of PrP‐Amyloid Formation in Mice Without Transmissible Spongiform Encephalopathy , 2012, Brain pathology.
[14] M. Jucker,et al. Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders , 2011, Annals of neurology.
[15] B. Caughey,et al. Prion Disease Blood Test Using Immunoprecipitation and Improved Quaking-Induced Conversion , 2011, mBio.
[16] Steven J Collins,et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.
[17] Brent Race,et al. Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays , 2010, PLoS pathogens.
[18] Melinda E. Lull,et al. Microglial activation and chronic neurodegeneration , 2010, Neurotherapeutics.
[19] P. Greengard,et al. Writing Memories with Light-Addressable Reinforcement Circuitry , 2009, Cell.
[20] S. Norley,et al. Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3−/− Mice , 2008, Journal of Virology.
[21] Richard C. Moore,et al. Genes contributing to prion pathogenesis. , 2008, The Journal of general virology.
[22] B. Chesebro,et al. Role of Erk1/2 activation in prion disease pathogenesis: Absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression , 2008, Journal of Neuroimmunology.
[23] A. Su,et al. Expression analysis of G Protein-Coupled Receptors in mouse macrophages , 2008, Immunome research.
[24] Sarah Medina,et al. Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes , 2008, BMC Genomics.
[25] Claudio Soto,et al. Protein misfolding and neurodegeneration. , 2008, Archives of neurology.
[26] Declan King,et al. High Titers of Transmissible Spongiform Encephalopathy Infectivity Associated with Extremely Low Levels of PrPSc in Vivo* , 2007, Journal of Biological Chemistry.
[27] B. Ghetti,et al. Accumulation of prion protein in the brain that is not associated with transmissible disease , 2007, Proceedings of the National Academy of Sciences.
[28] Jacques van Helden,et al. Evaluation of clustering algorithms for protein-protein interaction networks , 2006, BMC Bioinformatics.
[29] V. Perry,et al. TGFβ1 regulates the inflammatory response during chronic neurodegeneration , 2006, Neurobiology of Disease.
[30] Pamela J Skinner,et al. Gene expression alterations in brains of mice infected with three strains of scrapie , 2006, BMC Genomics.
[31] V. Perry,et al. MCP-1 and murine prion disease: Separation of early behavioural dysfunction from overt clinical disease , 2005, Neurobiology of Disease.
[32] G. J. Raymond,et al. The most infectious prion protein particles , 2005, Nature.
[33] H. Kretzschmar,et al. Cerebral gene expression profiles in sporadic Creutzfeldt–Jakob disease , 2005, Annals of neurology.
[34] Angus Lauder,et al. Accelerated Prion Disease in the Absence of Interleukin-10 , 2004, Journal of Virology.
[35] V. Perry,et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.
[36] S. Leurgans,et al. Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's Disease , 2002, Experimental Neurology.
[37] B. Permanne,et al. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.
[38] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[39] A. Johnston,et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus , 2000, Neuropathology and applied neurobiology.
[40] I. Mcconnell,et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy , 1999, The EMBO journal.
[41] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[42] J. Morris,et al. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.
[43] M. Gurney,et al. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .
[44] J. Rossier,et al. Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.
[45] A. Aguzzi,et al. Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.
[46] J Carter,et al. Molecular Pathology of Alzheimer's Disease , 2013 .
[47] I. Mcconnell,et al. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal , 1994, Molecular Neurobiology.
[48] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[49] Edward M. Reingold,et al. Graph drawing by force‐directed placement , 1991, Softw. Pract. Exp..
[50] D. Selkoe,et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.
[51] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[52] S. Prusiner,et al. A protease-resistant protein is a structural component of the Scrapie prion , 1983, Cell.
[53] E. Manning,et al. Early distribution of radioactive liposomes and scrapie infectivity in mouse tissues following administration by different routes , 1979 .
[54] H. Fraser,et al. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. , 1968, Journal of comparative pathology.
[55] H. Fraser,et al. Distribution of Experimentally Induced Scrapie Lesions in the Brain , 1967, Nature.
[56] T. Michoel,et al. Microglial brain regiondependent diversity and selective regional sensitivities to aging , 2015 .
[57] Anton J. Enright,et al. Network visualization and analysis of gene expression data using BioLayout Express3D , 2009, Nature Protocols.
[58] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[59] M. Gurney,et al. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. , 1998, Glia.